Cervavac Human Papilloma Virus Vaccine

Name: Cervavac Human Papilloma Virus Vaccine
Brand: Welox Pharma Private Limited
Price: 1700 INR
Availability: InStock

Price 1700 INR/ Piece

Get a Price/Quote

MOQ : 10 Pieces

Cervavac Human Papilloma Virus Vaccine Specification

Shelf Life
24 Month

Packaging Type
Vial

Indication
HPV infection, Cervical cancer prevention

Medicine Type
Injection

Physical Form
Liquid

Ingredients
Human Papilloma Virus-L1 protein

Treatments & Functions
Prevention of cervical cancer

Recommended For
Females aged 9-26 years

Quantity/Volume
1 Vial

Storage Instructions
Store at 2C to 8C

Dose/Strength(Eg : 1mg Or 1 Ml )
0.5 ml per dose

Multi-dose
No

Form
Injection

Injection Route
Intramuscular

Antigen Type
Recombinant HPV

Manufactured By
Serum Institute

Packing Type
Vial

Virus Types Covered
Types 16 & 18

Prescription Status
Non prescription

Cervavac Human Papilloma Virus Vaccine Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Pieces Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Cervavac Human Papilloma Virus Vaccine

Experience the exclusive Cervavac Human Papilloma Virus Vaccine, a groundbreaking solution designed to guard against the most potent strains of HPV. Manufactured by the renowned Serum Institute, this crowning innovation delivers breathtaking results in the fight against cervical cancer. Each single-dose vial (0.5 ml) contains recombinant HPV-L1 protein, targeting types 16 & 18, all in a stable liquid form for intramuscular injection. Jump on this preventative opportunity-grab Cervavac and ensure protection for females aged 9-26 years. Store safely at 2C to 8C. Non-prescription access makes prevention effortless for everyone!

Highlighting Features & Versatile Applications of Cervavac

Cervavac Human Papilloma Virus Vaccine stands out with its potent recombinant antigen, specifically engineered for the prevention of cervical cancer in females aged 9-26. Easy to administer via intramuscular injection, it is recommended for individuals at risk of HPV infections. The vaccine is solely used for direct injection, ensuring maximum efficacy at the site of application. Beyond primary prevention, Cervavac supports broader public health initiatives against HPV-related complications.

Certifications, Supply Capacity, and Pricing of Cervavac

Cervavac carries stringent certifications, underlining its high standard of safety and efficacy. The Serum Institute maintains robust supply ability, ensuring steady availability throughout India. Each 1-vial pack is protected with secure labeling and packaging, preserving its 24-month shelf life. The asking price reflects the expenditure required for advanced biotechnology and rigorous manufacturing standards. Contact your supplier or trader for current pricing and large order fulfillment details.

FAQ's of Cervavac Human Papilloma Virus Vaccine:

Q: How should Cervavac Human Papilloma Virus Vaccine be stored?

A: Cervavac should be stored in a refrigerator at temperatures between 2C to 8C to maintain its efficacy and stability.

Q: What virus types does Cervavac target?

A: Cervavac is formulated to protect against the Human Papilloma Virus types 16 and 18, which are primarily responsible for most cases of cervical cancer.

Q: When is the ideal age to receive the Cervavac vaccine?

A: The vaccine is recommended for females aged 9 to 26 years to ensure maximum protection before potential exposure to HPV.

Q: What is the application process for Cervavac?

A: Cervavac is administered as a 0.5 ml liquid injection via the intramuscular route. Dosage and administration should be performed as per healthcare guidelines.

Q: Where can I purchase Cervavac Human Papilloma Virus Vaccine?

A: Cervavac is available through authorized manufacturers, suppliers, and traders across India, with no prescription required for purchase.

Q: What are the primary benefits of using Cervavac?

A: This vaccine offers potent protection against HPV infections, significantly reducing the risk of developing cervical cancer in the target population.